My PCR
Create Account
Logo PCR

21 May 2025

Antithrombotic drugs for acute coronary syndromes in women

With the collaboration of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Spokesperson: A. Chieffo
Discussants: M. Kaluzna Oleksy, E. Rafflenbeul, G. Stefanini, M. Valgimigli, S. Yadav Rao
SHOW MORE

Summary

Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting female patient representation in clinical trials.

Learning Objectives

  • To enhance understanding of risk stratification for balancing ischemic and bleeding risks in managing ACS patients and multivessel disease and high bleeding risk
  • To explore evidence-based strategies for selecting and optimising antithrombotic therapy and revascularization approaches tailored to high bleeding risk patients
  • To discuss diagnostic algorithm and treatment for MINOCA patients

Presentations available when logged in:

  • Welcome and session objectives
  • Case 1 - Managing a female patient with high bleeding risk presenting with ACS and multivessel disease
  • Risk stratification and tailored antithrombotic therapy for this patient
  • Revascularisation strategies: timing, completeness, and PCI optimisation for this patient
  • Case 2 - A young woman with MINOCA
  • Personalised treatment strategies for MINOCA in this young female patient
  • Representation of such female patient in randomised clinical trials
  • Session evaluation and key learnings